| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$72 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:54AM |
$0.380 |
$0.500 |
risen by
31.58%
|
|
TNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Restart of copper production at Cloncurry Copper Project (CCP) in Queensland, Australia.
- First copper cathode produced and shipments commenced to Glencore under an offtake agreement.
- Operational focus on dewatering and development of CCP pits.
- Wallace North open pit pre-feasibility and environmental studies underway.
- Resource drilling at Vero Project achieved higher grades and increased resource confidence.
- Maintained strong safety record with no lost time injuries for the quarter.
- Cash outflows primarily related to production, project development, and exploration.
- Cash and investments detailed at the end of the quarter.
- Forward plans include ramping up copper production, further drilling at Vero, and advancing feasibility studies.
- Engagement with regulators and communities on environmental and project development matters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Belararox Limited (BRX) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:54AM |
$0.078 |
$0.094 |
risen by
20.51%
|
|
BRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling and resource delineation continued at the Belara Project.
- Updated Mineral Resource Estimate (MRE) targeted for completion following results.
- Metallurgical testwork and environmental baseline studies progressed.
- Exploration planning advanced for the Native Bee Project.
- Cash outflows primarily related to exploration and evaluation activities.
- Cash reserves reported at the end of the quarter.
- Payments to related parties consisted of director fees and consulting.
- No mining production or sales reported during the quarter.
- Focus remains on advancing both base and precious metals assets towards development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KGL Resources Limited (KGL) ORDINARY FULLY PAID |
Materials |
$162 |
Quarterly Activities and Cashflow Report
|
31 Jul 2025 9:53AM |
$0.100 |
$0.210 |
risen by
110%
|
|
KGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Jervois Copper Project continues to progress with further drilling and resource definition.
- Significant copper mineralization encountered in exploration activities.
- Engagement with potential project financiers and offtake partners is ongoing.
- Environmental approvals and permitting activities are advancing.
- Quarterly cash outflows primarily related to exploration and project development.
- Cash balance at quarter end was $9.1 million.
- Stakeholder engagement and community consultation activities are ongoing.
- The company is preparing for further project development steps in upcoming quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan High Conviction Trust (Managed Fund) (MHHT) MAGELLAN HIGH CONVICTION TRUST - ACTIVE ETF |
Financials |
$410 |
MHHT - Quarterly Portfolio Disclosure - 30 June 2025
|
31 Jul 2025 9:53AM |
$1.885 |
$1.865 |
fallen by
1.06%
|
|
| Orange Minerals NL (OMX) ORDINARY FULLY PAID |
Materials |
$14 |
OTCQB Listing Completed
|
31 Jul 2025 9:53AM |
$0.075 |
$0.081 |
risen by
8%
|
|
OMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Orange Minerals NL has completed its listing on the OTCQB Venture Market in the US.
- The company’s shares will trade under the symbol 'OMXMF'.
- Listing is designed to enhance visibility and access for North American investors.
- No new shares are being issued as part of the listing.
- The listing is expected to improve liquidity and broaden the investor base.
- Management considers this a significant step in international growth and development.
- The announcement date of the listing is 21 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solara Minerals Limited (SLA) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:52AM |
$0.280 |
$0.180 |
fallen by
35.71%
|
|
SLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Solara Minerals Limited provided its Quarterly Activities Report for the period ending 31 December 2023.
- The company is focused on critical minerals and battery metals, with its main project being the Calliope Project in Queensland, Australia.
- Fieldwork at the Calliope Project included soil sampling and mapping, leading to identification of areas with potential for lithium and rare earth elements.
- Solara Minerals progressed permitting and land access agreements to support upcoming drilling programs.
- Corporate activities included the completion of a share purchase plan, resulting in the raising of new funds to support exploration and operations.
- The company lodged its Appendix 5B Cash Flow Report, detailing cash flows from operating, investing, and financing activities for the quarter.
- Solara Minerals ended the quarter with a cash balance of $1.4 million, which is expected to support near-term exploration activities and corporate costs.
- No significant mining production or development activities occurred during the reporting period.
- The report also covers payments to related parties and their associates, primarily for directors’ fees and consulting services.
- Solara Minerals continues to assess new opportunities in the critical minerals sector while advancing its existing projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ridley Corporation Limited (RIC) ORDINARY FULLY PAID |
Consumer Staple |
$956 |
Investor Briefing Details - FY25 Full Year Results
|
31 Jul 2025 9:52AM |
$2.850 |
$2.550 |
fallen by
10.53%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$21 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:52AM |
$0.040 |
$0.044 |
risen by
10%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash receipts of $1.568 million, including customer receipts and R&D tax incentives
- Cash balance at quarter end was $2.412 million
- Continued growth in product sales, particularly FerriScan®, FerriSmart®, and HepaFat-AI®
- HepaFat-AI® received first sales and regulatory progress reported
- CardiacT2® regulatory and clinical development ongoing
- Investments in R&D and product development to expand liver and cardiac diagnostic portfolio
- Collaborations with global partners for distribution and clinical use
- Prudent cash management and continued focus on commercialisation strategies
- Appendix 4C included with detailed cash flow and expenditure breakdown
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$86 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:52AM |
$0.120 |
$0.140 |
risen by
16.67%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- IODM continued to onboard new customers and expand existing client relationships.
- Total cash receipts from customers for the quarter were $1.33 million.
- The company focused on product innovation and technological improvements, especially in its accounts receivable automation solution.
- IODM expanded its presence in international markets, particularly in the UK.
- Staff and administrative costs were the major areas of cash outflows.
- The company ended the quarter with a cash position of $2.37 million.
- Partnerships and collaboration initiatives were highlighted as key to future growth.
- The Appendix 4C report provides a detailed breakdown of cash flows and operational activities.
- IODM is committed to further investment in technology and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$32 |
Pause in Trading
|
31 Jul 2025 9:51AM |
$0.012 |
$0.031 |
risen by
158.33%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited requested a trading halt on 7 June 2024.
- The halt is due to a pending announcement about a capital raising.
- Trading in HeraMED’s securities will be paused until 11 June 2024 or the announcement is made.
- The company seeks to ensure the orderly market of its securities.
- HeraMED's Chairman, Mr. David Groberman, is the contact person for this matter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$19 |
Cleansing Notice
|
31 Jul 2025 9:51AM |
$0.160 |
$0.125 |
fallen by
21.88%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$4,187 |
Dividend/Distribution - AAI
|
31 Jul 2025 9:51AM |
$47.100 |
$72.800 |
risen by
54.56%
|
|
AAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Entity name: ALCOA CORPORATION
- Security on which the distribution will be paid: AAI - CDI 1:1 FOREIGN EXEMPT NYSE
- Announcement Type: New announcement
- Announcement Date: 31/7/2025
- Distribution Amount: USD 0.10000000
- Ex Date: 11/8/2025
- Record Date: 12/8/2025
- Payment Date: 28/8/2025
- Non-resident withholding tax will be deducted as required by U.S. tax law
- Default non-resident withholding tax rate is 30%
- Alcoa CDI holders can elect to receive dividend payments in different currencies through Computershare's Global wire payment solution
- Holders without valid banking details will have their payment withheld according to Alcoa's mandatory direct credit policy
- Ordinary dividend/distribution is unfranked
- Payment currency options include AUD, NZD, GBP
- Deadline for payment instructions: 12 August 2025, 17:00 AEDT
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$4,187 |
Dividend/Distribution - AAI
|
31 Jul 2025 9:51AM |
$47.100 |
$72.800 |
risen by
54.56%
|
|
AAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Dividend distribution amount is USD 0.10 per security.
- Payment date is 28 August 2025.
- Ex-date is 11 August 2025.
- Record date is 12 August 2025.
- Primary currency is USD, with options for AUD, NZD, or GBP.
- Non-resident withholding tax default rate is 30%.
- Payments via direct credit or cheque based on holder's location and details.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$212 |
Update - Notification of buy-back - CEH
|
31 Jul 2025 9:51AM |
$0.380 |
$0.545 |
risen by
43.42%
|
|
| Magellan Global Equities Fund (Currency Hedged) (MHG) |
Financials |
$104 |
MHG - Quarterly Portfolio Disclosure - 30 June 2025
|
31 Jul 2025 9:49AM |
$3.980 |
$4.110 |
risen by
3.27%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$134 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:49AM |
$0.095 |
$0.320 |
risen by
236.84%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma continued the development and regulatory expansion of SPL7013 (VIRALEZE™) antiviral nasal spray.
- The company advanced dendrimer-based drug delivery and pharmaceutical product programs.
- Ongoing collaborations with international pharmaceutical partners were maintained.
- Regulatory submissions and reviews for VIRALEZE™ continued in multiple regions.
- Appendix 4C reported cash outflows primarily related to R&D and commercial activities.
- Starpharma maintained a strong cash position at quarter end.
- The report detailed operational, financial, and strategic progress for the quarter ended 31 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$6 |
Catalina intersects wide gold zones in maiden drilling
|
31 Jul 2025 9:49AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Catalina Resources Ltd completed a maiden diamond drilling program at the CTN project.
- Eight drill holes totaling 1,180.5 meters were completed.
- Drilling targeted the El Tambo and La Maruja prospects.
- Wide gold mineralized zones were intersected in several drill holes.
- Significant gold grades and thicknesses were reported, including high-grade intervals.
- Results validate the geological model and support ongoing exploration activities.
- Plans are underway for further drilling to expand and define mineralized zones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Burgundy Diamond Mines Limited (BDM) ORDINARY FULLY PAID |
Materials |
$24 |
Ekati Life of Mine Plan Update
|
31 Jul 2025 9:49AM |
$0.033 |
$0.017 |
fallen by
48.48%
|
|
BDM - Price-sensitive ASX Announcement
Full Release
Key Points
- BDM released an updated Ekati Life of Mine Plan in March 2024.
- The updated plan extends Ekati's mine life through to 2031.
- Ore reserves and resources have increased due to exploration and optimized mine planning.
- The plan outlines production forecasts, operational schedules, and capital expenditure estimates.
- Diamond output is expected to remain robust over the life of mine horizon.
- Strategic advancements have supported increased confidence in resource and reserve bases.
- Operational improvements and cost efficiencies are prioritized.
- Environmental responsibility and community engagement remain central to company strategy.
- The update includes an assessment of risks and opportunities for future growth.
- BDM is committed to sustainable development and long-term value creation for stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$16 |
FY25 Q4 Activity Report and Appendix 4C
|
31 Jul 2025 9:49AM |
$0.015 |
$0.008 |
fallen by
46.67%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth and new contract wins in FY25 Q4.
- Continued expansion of recurring revenue base.
- Solid demand for cybersecurity products across partners and resellers.
- Ongoing investments in product development and strategic partnerships.
- Focus on cost management and operational efficiency.
- Improved sales pipeline and positive outlook for coming quarters.
- Appendix 4C details cash receipts, payments, and end-of-quarter cash position.
- Emphasis on maintaining adequate cash reserves and prudent capital allocation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Metals Limited (EME) ORDINARY FULLY PAID |
Energy |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.085 |
$0.075 |
fallen by
11.76%
|
|
EME - Price-sensitive ASX Announcement
Full Release
Key Points
- EME maintained an active exploration and project development program across its uranium assets.
- The Bigrlyi Joint Venture remains the primary focus, with ongoing technical and environmental studies.
- Joint venture arrangements continue with Vimy Resources and Northern Territory Uranium Pty Ltd.
- Financial management remained cautious, with clear reporting on cash flows and expenditures.
- The company holds significant uranium tenements in both the Northern Territory and Western Australia.
- EME emphasized regulatory compliance and provided updates on tenement status.
- The report discusses broader market conditions and EME's readiness to capitalize on uranium sector improvements.
- No production or sales occurred during the quarter; activities centered on exploration and asset management.
- Appendix 5B details cash outflows and receipts for the quarter.
- EME retains a strong cash position to support ongoing project activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.057 |
$0.084 |
risen by
47.37%
|
|
ACM - Price-sensitive ASX Announcement
Full Release
Key Points
- ACM advanced exploration across its critical mineral projects in Western Australia.
- The company focused on lithium, rare earths, and battery metals.
- Key projects included Cooletha, Rankin Dome, and Shaw.
- Activities involved soil sampling, mapping, and heritage surveys.
- Completion of the first drilling program at Cooletha with positive geochemical results.
- ACM listed on the ASX during the reporting period.
- Financial report includes summary of cash flows and exploration expenditure.
- ACM maintains sufficient funding for future exploration activities.
- No production or significant sales reported in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hydrix Limited (HYD) ORDINARY FULLY PAID |
Information Technology |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:48AM |
$0.018 |
$0.012 |
fallen by
33.33%
|
|
HYD - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly revenue reached $3.3 million, up 47% from the previous quarter.
- Operating cash flow was positive at $0.5 million for the quarter.
- Revenue grew 32% compared to the prior corresponding period.
- Signed a distribution agreement for the AngelMed Guardian device in Taiwan.
- Medical and Engineering segments showed strong performance.
- Expansion of sales channels in Asia-Pacific region continued.
- Focus on innovative medical technology and cardiovascular portfolio.
- Investment in business development and sales capability.
- Cost management and improved cash position were prioritized.
- Report covers cash flows, investments, and related party transactions.
- Positive outlook expressed for the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$77 |
June 2025 Quarterly Activities and Cashflow Report
|
31 Jul 2025 9:46AM |
$0.070 |
$0.160 |
risen by
128.57%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Chaketma Bankable Feasibility Study advanced with technical workstreams ongoing.
- Pilot beneficiation and phosphoric acid test work continued.
- Progress made on resource drilling and environmental/permitting workstreams.
- Positive community and stakeholder engagement initiatives undertaken.
- Strong cash position reported at quarter end.
- No significant health, safety or environmental incidents occurred.
- Company focused on advancing Chaketma to production and progressing offtake and financing discussions.
- Quarterly cashflow report included with details on expenditure and cash balance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RemSense Technologies Limited (REM) ORDINARY FULLY PAID |
Industrials |
$8 |
Trading Halt
|
31 Jul 2025 9:46AM |
$0.034 |
$0.039 |
risen by
14.71%
|
|
REM - Price-sensitive ASX Announcement
Full Release
Key Points
- RemSense Technologies Limited requested a trading halt on its securities.
- The trading halt is pending an announcement regarding a capital raising.
- The halt is intended to remain until 13 June 2024 or until the announcement is made.
- The request is made to ensure an orderly market.
- The announcement is in accordance with ASX Listing Rule requirements.
- The request was authorized by the company's Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Halo Technologies Holdings Ltd (HAL) ORDINARY FULLY PAID |
Financials |
$10 |
June 2025 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 9:46AM |
$0.031 |
$0.035 |
risen by
12.90%
|
|
HAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers operational and financial activities for the June 2025 quarter.
- Highlights achievements in product development and customer growth.
- Provides Appendix 4C cash flow statement including receipts, expenditures, and investment activities.
- Details on partnership activities and strategic initiatives.
- Continued focus on technology platform scaling and customer acquisition.
- Emphasis on prudent cost management.
- Management reiterates commitment to growth and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
